Moderna Stock (NASDAQ: MRNA) stock price, news, charts, stock research, profile.
Open | $120.750 |
Close | $117.310 |
Volume / Avg. | 4.239M / 3.928M |
Day Range | 116.732 - 124.900 |
52 Wk Range | 62.550 - 142.790 |
Market Cap | $44.950B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 7.21% |
Days to Cover | 6.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moderna (NASDAQ: MRNA) through any online brokerage.
Other companies in Moderna’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Moderna (NASDAQ: MRNA) was reported by UBS on Tuesday, May 7, 2024. The analyst firm set a price target for 151.00 expecting MRNA to rise to within 12 months (a possible 28.74% upside). 31 analyst firms have reported ratings in the last year.
The stock price for Moderna (NASDAQ: MRNA) is $117.29 last updated May 10, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Moderna.
Moderna’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Moderna.
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.